AGO2 and hypertensive disorder: For example, tail vein injection of rAAV-miR-21 can alleviate pathological injury in spontaneous hypertension rats.[8] Exogenous delivery of mitochondrial-targeted rAAV9-Ago2 can prevent cardiac dysfunction in diabetic mice.